U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C23H24N8O3
Molecular Weight 460.4885
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Zasocitinib

SMILES

CNC1=CC(NC2=CC=CN(C2=O)C3=CC=CC=N3)=NC4=C(C=NN14)C(=O)N[C@@H]5CC[C@H]5OC

InChI

InChIKey=BWINBHTTZLVXGT-NVXWUHKLSA-N
InChI=1S/C23H24N8O3/c1-24-20-12-18(27-16-6-5-11-30(23(16)33)19-7-3-4-10-25-19)29-21-14(13-26-31(20)21)22(32)28-15-8-9-17(15)34-2/h3-7,10-13,15,17,24H,8-9H2,1-2H3,(H,27,29)(H,28,32)/t15-,17-/m1/s1

HIDE SMILES / InChI

Approval Year

Name Type Language
Zasocitinib
INN  
Official Name English
TAK-279
Code English
TAK279
Code English
zasocitinib [INN]
Common Name English
NDI-034858
Code English
NDI034858
Code English
PYRAZOLO(1,5-A)PYRIMIDINE-3-CARBOXAMIDE, N-((1R,2R)-2-METHOXYCYCLOBUTYL)-7-(METHYLAMINO)-5-((2-OXO(1(2H),2'-BIPYRIDIN)-3-YL)AMINO)-
Systematic Name English
N-[(1R,2R)-2-methoxycyclobutyl]-7-(methylamino)-5- [(2-oxo[1(2H),2'-bipyridin]-3-yl)amino]-pyrazolo[1,5- a]pyrimidine-3-carboxamide
Systematic Name English
Code System Code Type Description
CAS
2272904-53-5
Created by admin on Sat Dec 16 15:41:43 GMT 2023 , Edited by admin on Sat Dec 16 15:41:43 GMT 2023
PRIMARY
FDA UNII
C293MNS6TQ
Created by admin on Sat Dec 16 15:41:43 GMT 2023 , Edited by admin on Sat Dec 16 15:41:43 GMT 2023
PRIMARY
PUBCHEM
137441492
Created by admin on Sat Dec 16 15:41:43 GMT 2023 , Edited by admin on Sat Dec 16 15:41:43 GMT 2023
PRIMARY
NCI_THESAURUS
C199133
Created by admin on Sat Dec 16 15:41:43 GMT 2023 , Edited by admin on Sat Dec 16 15:41:43 GMT 2023
PRIMARY
SMS_ID
300000041009
Created by admin on Sat Dec 16 15:41:43 GMT 2023 , Edited by admin on Sat Dec 16 15:41:43 GMT 2023
PRIMARY
INN
12519
Created by admin on Sat Dec 16 15:41:43 GMT 2023 , Edited by admin on Sat Dec 16 15:41:43 GMT 2023
PRIMARY